Zairul-Nizam Z F, Gul Y A
Orthopaedic Unit, Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Hospital Kuala Lumpur, Jalan Masjid, 50586 Kuala Lumpur, Malaysia.
J Orthop Surg (Hong Kong). 2003 Dec;11(2):178-83. doi: 10.1177/230949900301100213.
To survey Malaysian orthopaedic surgeons' attitudes to and use of venous thromboembolic disease prophylaxis.
A total of 144 orthopaedic surgeons from various governmental and private institutions responded to a questionnaire.
Only slightly more than half of these surgeons considered venous thromboembolic disease as common a problem in Malaysia as in western countries. The majority of surgeons (91.0%) reported using prophylaxis selectively for patients based on various indicators such as risk grading of surgery, obesity, and malignancy etc. Bleeding tendencies were cited as the greatest fear against the use of pharmacological prophylaxis. Low-molecular-weight heparin appeared to be the most commonly used pharmacological prophylaxis, used either singly or in combination with other forms of prophylaxis. The majority of surgeons employed prophylaxis until their patients were mobile.
There should be greater awareness among surgeons in Malaysia of the need for protection against venous thromboembolic disease. Current practice needs to be reviewed and further recommendations made for existing protocols.
调查马来西亚骨科医生对静脉血栓栓塞性疾病预防的态度及应用情况。
来自不同政府和私立机构的144名骨科医生对一份问卷进行了回复。
这些医生中只有略超过一半的人认为静脉血栓栓塞性疾病在马来西亚与西方国家一样常见。大多数医生（91.0%）报告称根据手术风险分级、肥胖、恶性肿瘤等各种指标为患者选择性地使用预防措施。出血倾向被认为是使用药物预防的最大顾虑。低分子量肝素似乎是最常用的药物预防措施，单独使用或与其他预防形式联合使用。大多数医生在患者能够活动之前一直采用预防措施。
马来西亚的外科医生应更清楚地认识到预防静脉血栓栓塞性疾病的必要性。需要对当前的做法进行审查，并对现有方案提出进一步建议。
